Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double‐blind randomized controlled trial (BEGIN: ADD TO GLP‐1 Study)

AIM: To evaluate the efficacy and safety of adding insulin degludec (IDeg) to treatment in patients with type 2 diabetes receiving liraglutide and metformin and qualifying for treatment intensification because of inadequate glycaemic control. METHODS: In this 26‐week, double‐blind trial, patients wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Aroda, V. R., Bailey, T. S., Cariou, B., Kumar, S., Leiter, L. A., Raskin, P., Zacho, J., Andersen, T. H., Philis‐Tsimikas, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074260/
https://www.ncbi.nlm.nih.gov/pubmed/26990378
http://dx.doi.org/10.1111/dom.12661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074260/
https://www.ncbi.nlm.nih.gov/pubmed/26990378
http://dx.doi.org/10.1111/dom.12661

Ejemplares similares